5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.84▲ | 1.83▲ | 1.83▲ | 1.88▼ | 1.67▲ |
MA10 | 1.84▲ | 1.83▲ | 1.84▲ | 1.80▲ | 2.10▼ |
MA20 | 1.83▲ | 1.83▲ | 1.86▼ | 1.68▲ | 3.16▼ |
MA50 | 1.82▲ | 1.86▼ | 1.86▼ | 2.17▼ | 4.82▼ |
MA100 | 1.83▲ | 1.85▲ | 1.69▲ | 3.27▼ | 4.31▼ |
MA200 | 1.86▼ | 1.66▲ | 1.83▲ | 4.79▼ | 6.35▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.003▲ | -0.005▼ | 0.075▲ | -0.083▼ |
RSI | 65.621▲ | 52.237▲ | 50.956▲ | 47.351▼ | 30.586▼ |
STOCH | 59.444 | 52.103 | 28.563 | 86.283▲ | 12.334▼ |
WILL %R | -14.286▲ | -42.105 | -42.105 | -17.213▲ | -80.966▼ |
CCI | 162.222▲ | 84.337 | 48.421 | 57.669 | -71.686 |
Sunday, April 20, 2025 05:00 PM
Annexon, Inc. (NASDAQ:ANNX – Get Free Report) was the recipient of a large decline in short interest during the month of March.As of March 31st, there was short interest totalling 8,240,000 ...
|
Sunday, April 20, 2025 05:00 PM
Annexon, Inc. (NASDAQ:ANNX – Get Free Report) was the recipient of a large decline in short interest during the month of March.As of March 31st, there was short interest totalling 8,240,000 ...
|
Wednesday, April 16, 2025 09:05 AM
BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.87 | 1.90 | 1.795 | 1.855 | 1,109,522 |
30/04/25 | 1.87 | 1.88 | 1.7947 | 1.86 | 1,595,746 |
29/04/25 | 1.89 | 1.955 | 1.86 | 1.90 | 975,604 |
28/04/25 | 1.88 | 1.95 | 1.84 | 1.89 | 816,658 |
25/04/25 | 1.89 | 1.90 | 1.80 | 1.88 | 877,980 |
24/04/25 | 1.84 | 1.91 | 1.78 | 1.91 | 1,581,583 |
23/04/25 | 1.80 | 1.96 | 1.77 | 1.84 | 3,178,064 |
22/04/25 | 1.72 | 1.83 | 1.62 | 1.76 | 4,235,239 |
21/04/25 | 1.42 | 1.77 | 1.40 | 1.68 | 3,604,870 |
17/04/25 | 1.42 | 1.47 | 1.405 | 1.46 | 870,816 |
|
|
||||
|
|
||||
|
|